Autonomix Medical, Inc. (AMIX)

Autonomix Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Selling, General & Admin	6.56	5.25	1.25	13.59
Research & Development	4.73	2.23	0.75	0
Other Operating Expenses	0.3	-	-	-
Operating Expenses	11.59	7.47	1.99	13.59
Operating Income	-11.59	-7.47	-1.99	-13.59
Interest Expense	-0.18	-0.08	-	-0.22
Interest & Investment Income	0.35	0.13	-	-
Other Non Operating Income (Expenses)	-	-8	-	0.31
EBT Excluding Unusual Items	-11.41	-15.43	-1.99	-13.5
Other Unusual Items	-	-	-	0.17
Pretax Income	-11.41	-15.43	-1.99	-13.33
Net Income	-11.41	-15.43	-1.99	-13.33
Preferred Dividends & Other Adjustments	-	-	-	-0.49
Net Income to Common	-11.41	-15.43	-1.99	-12.84
Shares Outstanding (Basic)	2	1	1	0
Shares Outstanding (Diluted)	2	1	1	0
Shares Change (YoY)	69.73%	73.12%	480.20%	-
EPS (Basic)	-6.46	-14.82	-3.31	-123.94
EPS (Diluted)	-6.46	-14.82	-3.31	-123.94
Free Cash Flow	-8.27	-6.67	-1.85	-0.39
Free Cash Flow Per Share	-4.68	-6.41	-3.08	-3.74
EBITDA	-11.41	-7.39	-	-
D&A For EBITDA	0.18	0.08	-	-
EBIT	-11.59	-7.47	-1.99	-13.59
Advertising Expenses	-	1.8	-	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q